Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-05

FDA Approved: ABIRATERONE ACETATE — Supplemental Application (NORTHSTAR RX LLC)

View source ↗

Summary

FDA approved a supplemental application for abiraterone acetate (generic version). The product is manufactured by NorthStar RX LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)